Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.839
+0.004 (0.47%)
At close: Mar 9, 2026, 4:00 PM EDT
0.850
+0.011 (1.31%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Citius Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Net Income | -35.89 | -37.43 | -39.14 | -32.54 | -33.64 | -23.05 | |
| Depreciation & Amortization | 0.72 | 0.21 | 0.21 | 0.19 | 0.18 | 0.16 | |
| Stock-Based Compensation | 12.79 | 10.86 | 12.12 | 6.72 | 4.28 | 1.52 | |
| Other Operating Activities | -1.91 | -1.25 | 0.29 | 0.58 | 0.58 | -0.17 | |
| Change in Accounts Receivable | -4.05 | - | - | - | - | - | |
| Change in Inventory | -6.89 | -12.65 | -2.13 | - | - | - | |
| Change in Accounts Payable | 3.66 | 8.77 | 2 | 1.76 | -0.11 | -0.58 | |
| Change in Other Net Operating Assets | -3.27 | 4.94 | -1.55 | -5.77 | 0.35 | -2.14 | |
| Operating Cash Flow | -34.84 | -26.55 | -28.2 | -29.06 | -28.36 | -24.25 | |
| Capital Expenditures | - | - | - | - | - | -0.01 | |
| Sale (Purchase) of Intangibles | -10.15 | -5.75 | -5 | - | - | -40 | |
| Investing Cash Flow | -10.15 | -5.75 | -5 | - | - | -40.01 | |
| Short-Term Debt Issued | - | 1.3 | - | - | - | - | |
| Total Debt Issued | 1.3 | 1.3 | - | - | - | - | |
| Short-Term Debt Repaid | - | -0.3 | - | - | - | -0.17 | |
| Total Debt Repaid | -0.3 | -0.3 | - | - | - | -0.17 | |
| Net Debt Issued (Repaid) | 1 | 1 | - | - | - | -0.17 | |
| Issuance of Common Stock | 50.61 | 32.3 | 13.8 | 15.03 | - | 127.71 | |
| Other Financing Activities | - | - | -3.83 | -1.2 | - | -7.07 | |
| Financing Cash Flow | 51.61 | 33.3 | 9.97 | 13.83 | - | 120.47 | |
| Net Cash Flow | 6.62 | 1 | -23.23 | -15.23 | -28.36 | 56.21 | |
| Free Cash Flow | -34.84 | -26.55 | -28.2 | -29.06 | -28.36 | -24.26 | |
| Free Cash Flow Per Share | -2.39 | -2.40 | -4.19 | -4.80 | -4.85 | -5.58 | |
| Cash Interest Paid | 0.2 | 0.19 | - | - | - | 0.04 | |
| Levered Free Cash Flow | -40.53 | -23.38 | 8.02 | -19.85 | -15.94 | -55.61 | |
| Unlevered Free Cash Flow | -40.26 | -23.21 | 8.02 | -19.85 | -15.94 | -55.61 | |
| Change in Working Capital | -10.55 | 1.05 | -1.69 | -4.01 | 0.24 | -2.72 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.